Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Kmart delays Q3 filing

This article was originally published in The Tan Sheet

  • News

Executive Summary

Mass merchandiser anticipates filing third quarter 10-Q and monthly operating reports for October and November with the SEC by Dec. 23. Amended 2001 annual report and quarterly reports for first two quarters of 2002 will follow, Kmart says in Dec. 16 1announcement. Delay for filing Q3 (ended Oct. 30) report is due to restatement of prior fiscal years and first and second quarters of this year, retailer explains. Retailer was delisted by New York Stock Exchange effective Dec. 19. Stock will now be traded on OTC Bulletin Board...

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

Califf Says US FDA Ready If Human Avian Flu Infections Jump

Beyond CAR-Ts: Cell-Based Gene Therapy Sponsors Are ‘Branching Out,’ CBER’s Marks Says

Accelerated Approval: Withdrawing Gene Therapies Could Be Easier Than Small Molecules

Netherlands Pilots New Scientific Advice Service For Clinical Trials

See All
UsernamePublicRestriction

Register

PS094942

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By